Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)

NCT00799877 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT00799877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00799877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
September 26, 2008
Completion date
February 13, 2023
Enrollment
6,065 (actual)
Sites
339

Conditions

As the registry lists them; a condition with its own page is linked.

chronic plaque psoriasis